I. COMMENCED TRADING IN MAY | ||||||||
Company (Symbol)# | Date Filed | Date Comm. | Shares/Units (M) | Price | Shares Out (M)@ | Lead, Other Underwriters | Gross (US$M) | Post-Offering Market Cap (M)% |
INITIAL OFFERINGS | ||||||||
There were no initial public offerings conducted in May. | ||||||||
Total: $0M | ||||||||
Number of IPOs in May: 0 | ||||||||
Average value of May IPOs: $0M | ||||||||
Number of IPOs in 2009: 0 | ||||||||
Total raised in IPOs in 2009: $0M | ||||||||
Average value of IPOs in 2009: $0M | ||||||||
FOLLOW-ON OFFERINGS | ||||||||
Company (Symbol)# | Date Filed | Date Comm. | Shares/Units (M) | Price | Shares Out (M)@ | Lead, Other Underwriters | Gross (M) | Post-Offering Market Cap (M)% |
Cephalon Inc. (CEPH)1 | 5/20/09 | 5/20/09 | 5S and notes | $60 | 73.6 | Deutsche Bank Sec. | $800 | $4,416 |
Dendreon Corp. (DNDN)2 | 5/8/09 | 5/8/09 | 10.7S | $19.20 | 114.1 | Deutsche Bank Sec. | $205.4 | $2,190.72 |
Medivation Inc. (MDVN)3 | 5/27/09 | 5/28/09 | 2.75S | $21 | 32.9 | J.P. Morgan Securities Wedbush PacGrow Life Sci. |
$57.75 | $690.9 |
Total: $1,063.15M | ||||||||
Number of follow-on offerings in May: 3 | ||||||||
Average value of May follow-ons: $354.4M | ||||||||
Number of follow-on offerings in 2009: 8 | ||||||||
Total raised in follow-ons in 2009: $1,591.11M | ||||||||
Average value of follow-ons in 2009: $198.89M | ||||||||
Notes: | ||||||||
# Unless otherwise indicated, shares are traded on the Nasdaq exchange. | ||||||||
@ This column reflects the shares outstanding following the offering, when disclosed. | ||||||||
% Market capitalization is calculated based on the offering price. | ||||||||
Currency conversions are based on exchange rates at the time of the deal. | ||||||||
1 Cephalon's overallotment option: 750,000 shares, and $65 million in notes. The notes option was fully exercised and is included in the gross amount raised. | ||||||||
2 Dendreon's overallotment option: 1.28M shares. | ||||||||
3 Medivation's overallotment option: 412,500 shares. | ||||||||
II. FILED AND PENDING | ||||||
Company (Symbol/Proposed Symbol)# | Date Filed | Shares/Units (M) | Price Range | Shares Out (M)@ | Lead, Other Underwriters | Value (M) |
INITIAL OFFERINGS | ||||||
Omeros Corp. (OMER) | 1/10/08 | N/A | N/A | N/A | Deutsche Bank Securities Pacific Growth Equities Leerink Swann LLC Needham & Co. LLC |
$115 |
Prometheus Laboratories Inc. (RXDX) | 12/19/07 | N/A | N/A | N/A | Goldman Sachs & Co. Credit Suisse (co-lead) Banc of America Securities Cowen & Co. Pacific Growth Equities LLC |
$100 |
Notes: | ||||||
# Unless otherwise indicated, shares are traded on the Nasdaq exchange; general shelf registration statements are not included until action is taken on the filing. * Stock symbols for companies seeking to complete IPOs are proposed. @ This column reflects the shares outstanding following the offering, when disclosed. N/A = Not available, applicable or reported. | ||||||
The value of all offerings is based on either the midpoint of the price range listed in the company's SEC filing or the most recent closing stock price before the offering was announced. In some cases, the company has not disclosed the number of shares to be offered or a price range. Then, the value is the maximum aggregate offering price listed in the SEC filing. |